Clareo Technology
We empower labs and clinics to make better drugs and improve patient care through a deeper understanding of how the immune system works.
ClAIRity
Current immune profiling technologies lack the resolution needed to understand the impact of immune system diversity on human health, obscuring associations between immune function and clinical outcomes and impeding development of effective biomarkers, treatments, and prophylactics. Clareo technology makes better data possible.
ProfilAIR
The first RNA-based assay for profiling complete immune receptor transcripts
Sequence variation in expressed V, D, J, and C genes influences disease responses. Our ProfilAIR technology provides complete coverage of these regions, enabling:
- Accurate V(D)J allele discrimination
- Improved characterization of clonal lineages
- Variant detection in 5’ untranslated regions (UTR)
- Resolution of subisotype and constant domain allelic variation
- Transparent data analysis workflows and deliverables (raw and curated data)
GenotypAIR
The first assay for complete genomic characterization of immune receptor loci
The adaptive immune receptor loci are among the most genetically diverse and complex regions in the human genome. Our GenotypAIR technology unlocks direct connections between an individual’s genome and their immune response, delivering:
- Cost-effective comprehensive characterization of personalized immunogenetic profiles
- High-resolution immune receptor gene curation
- Complete genotyping of coding and non-coding single-nucleotide and large structural variants, including novel variation